Procognia
Ruth Ben Yakar
ruth@nullprocognia.com
+ 972-8-8634300
Procognia (Israel) Ltd. (TASE: PRCG) is an innovative biotech company expert in glycobiology and specifically in glycoanalysis. Based on its vast expertise, know-how and strong intellectual property, the company developed four platforms: analytics, diagnostics, stem cells and therapeutic antibodies.
Procognia is committed to leverage its glycobiology and technological expertise for the development of highly efficacious and safe biopharmaceuticals, improved cancer diagnostic tools and stem cells treatments.